Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Olive oil phenols and neuroprotection.
Corticosteroids for treating optic neuritis.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Santhera Receives European Marketing Authorization for Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Celiac disease and multiple sclerosis in the northwest of Iran.
Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes.
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Ocrelizumab in multiple sclerosis: risks and benefits.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Pages
« first
‹ previous
…
115
116
117
118
119
120
121
122
123
…
next ›
last »